SYNERGISTIC IMPACT OF EXERCISE AND GLP-1 RECEPTOR AGONIST TREATMENT: ADDRESSING METABOLIC SYNDROME, ABDOMINAL OBESITY, AND INFLAMMATION

Jakub Kuśmierski; Martyna Kuśmierska

doi:10.5114/hpc.2024.139680

eISSN: 2354-0265
ISSN: 2353-6942

Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO

Current issue Archive Online first About the journal Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

Send email

Copy url:

Letter to the Editor

SYNERGISTIC IMPACT OF EXERCISE AND GLP-1 RECEPTOR AGONIST TREATMENT: ADDRESSING METABOLIC SYNDROME, ABDOMINAL OBESITY, AND INFLAMMATION

Jakub Kuśmierski

¹

,

Martyna Kuśmierska

²

Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
Independent Public Health Care Facility, Municipal Hospital Complex in Chorzów, Poland

Health Prob Civil.

DOI: https://doi.org/10.5114/hpc.2024.139680

Online publish date: 2024/05/17

Article file

- Kuśmierski et al (2).pdf [0.44 MB]

Get citation

PlumX metrics:

1. Sandsdal RM, Juhl CR, Jensen SBK, Lundgren JR, Janus C, Blond MB, et al. Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial. Cardiovasc Diabetol. 2023; 22(1): 41. https://doi.org/10.1186/s12933-023-01765-z

2. Purnell JQ. Definitions, classification, and epidemiology of obesity. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.

3. Rubino F, Puhl RM, Cummings DE, Eckel RH, Ryan DH, Mechanick JI, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020; 26(4): 485-497. https://doi.org/10.1038/s41591-020-0803-x

4. Khanna D, Welch BS, Rehman A. Pathophysiology of obesity. Treasure Island (FL): StatPearls Publishing; 2024.

5. Ansari HUH, Qazi SU, Sajid F, Altaf Z, Ghazanfar S, Naveed N, et al. Efficacy and safety of glucagon-like peptide-1 receptor agonists on body weight and cardiometabolic parameters in individuals with obesity and without diabetes: a systematic review and meta-analysis. Endocr Pract. 2024; 30(2): 160-171. https://doi.org/10.1016/j.eprac.2023.11.007

Copyright: © 2024 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

SYNERGISTIC IMPACT OF EXERCISE AND GLP-1 RECEPTOR AGONIST TREATMENT: ADDRESSING METABOLIC SYNDROME, ABDOMINAL OBESITY, AND INFLAMMATION

Jakub Kuśmierski 1 , Martyna Kuśmierska 2

Jakub Kuśmierski

¹

,

Martyna Kuśmierska

²